James Woodruff Lillie, Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 721 shares at $28.28 ($20K) on 2026-05-07, disclosed to the SEC on 2026-05-11.
Scheduled sale ($20k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.5M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $123K | — | Filing → |